Colorectal Cancer Clinical Trial
— FC-VEOfficial title:
Comparison of Albumin and Ringer's Solution for Optimization of the Plasma Volume and Hemodynamics During Laparoscopic Surgery.
A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | October 31, 2025 |
Est. primary completion date | October 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Written consent to participate in the study - For women: relevant contraceptive, menopausal or a negative pregnancy test. - ASA category I to III - Laparoscopic abdominal surgery, with a duration of at least 90 minutes. - 18 to 80 years Exclusion Criteria: - Patients with known cardiac failure - <18 or >80 years - known allergy to albumin - extracellular hyperhydration or hypervolemia - kidney failure - pregnancy or planned pregnancy |
Country | Name | City | State |
---|---|---|---|
Sweden | Vrinnevi Hospital | Norrköping | Östergötland |
Lead Sponsor | Collaborator |
---|---|
Joachim Zdolsek |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Plasma volume expansion after a fluid bolus | Plasma volume using hemoglobin as an indicator of dilution | 60 minutes after an intravenous fluid bolus | |
Secondary | Fluid Balance | Calculations of fluid balance | 18 to 24 hours | |
Secondary | Stroke Volume | Change in stroke volume, measured with Cardio Q (oesophageal Doppler monitoring (ODM)) | 60 minutes after an intravenous fluid bolus | |
Secondary | Arterial Blood Pressure | Mean Arterial Pressure, measured with an arterial line. | 60 minutes after an intravenous fluid bolus | |
Secondary | Heart Rate | Heart rate, measured with ECG and pulseoximeter. | 60 minutes after an intravenous fluid bolus | |
Secondary | Bioimpedance | Bioimpedance measures, resistance and impedance converted to volume of body fluid compartments. | 18 to 24 hours | |
Secondary | Serum Creatinin | Serum Creatinin as a measure of kidney function | 18 to 24 hours | |
Secondary | arterial pH | Influence of a fluid bolus on arterial blood gases | 60 minutes after an intravenous fluid bolus | |
Secondary | arterial Base Excess | Influence of a fluid bolus on arterial blood gases | 60 minutes after an intravenous fluid bolus | |
Secondary | arterial serum sodium | Influence of a fluid bolus on Sodium concentration | 60 minutes after an intravenous fluid bolus | |
Secondary | arterial serum chloride | Influence of a fluid bolus on Chloride concentrations | 60 minutes after an intravenous fluid bolus |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |